Assistant Clinical Professor of Medicine, Case West Res University
Endocrinology
Dr. Angelo A. Licata, MD
|
|
Give Review
Dr. Angelo A. Licata practices Endocrinology. He attended University of Rochester School of Medicine and Dentistry. He has 4 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Northern Ohio Live" and "Fellow (FACE)". Angelo Licata has written publications. He has 97 publications published with PubMed. The lastest paper is: 'Asymptomatic hypercalcemia in a 51-year-old woman.' Angelo Licata is registered with Medicare and accepts Medicare payments.
Publications
- Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
- Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome.
- Hypercalcemia and Acromegaly - Clarifying the Connections. A Case Report and Review of the Literature.
- A novel lunar bed rest analogue.
- Bone mineral density testing: Is a T score enough to determine the screening interval?
- Bone density, bone quality, and FRAX: changing concepts in osteoporosis management.
- New tools for detecting occult monoclonal gammopathy, a cause of secondary osteoporosis.
- Gastrointestinal side effects of bisphosphonates obscuring vascular disease.
- Dual-energy X-ray absorptiometry diagnostic discordance between Z-scores and T-scores in young adults.
- Biochemical markers of bone turnover: useful but underused.
- DXA-generated Z-scores and T-scores may differ substantially and significantly in young adults.
- Update on therapy for osteoporosis.
- Secondary osteoporosis: are we recognizing it?
- Assessment of bone and mineral metabolism in inflammatory bowel disease: case series and review.
- Diagnosing primary osteoporosis: it's more than a T score.
- Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
- Exercise and pharmacological countermeasures for bone loss during long-duration space flight.
- Osteoporosis, teriparatide, and dosing of calcium and vitamin D.
- Systemic effects of fluticasone nasal spray: report of 2 cases.
- Discovery, clinical development, and therapeutic uses of bisphosphonates.
- Hip fracture patients are not treated for osteoporosis: a call to action.
- Central obesity and hypertension: the role of plasma endothelin.
- Symmetrical bone scan in a patient with acute hypercalcemia.
- A woman with a long history of abdominal pain.
- Secretion of glucosamine-containing macromolecules by rat parathyroid glands in tissue culture.
- Measurement of sialyl transferase activity and serum glycoproteins in malignant and beningn (hyperparathyroid) hypercalcemia.
- Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.
- Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
- C4BQ0: a genetic marker of familial HCV-related liver cirrhosis.
- Spontaneous return of normocalcemia. Association with long-term hypoparathyroidism.
- [Adrenal pseudocyst: case report and review of the literature].
- Evaluation of the prognostic accuracy of Astler-Coller''s and Jass'' classifications of colorectal cancer.
- Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study.
- Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
- Hemorrhoidal stapler prolapsectomy vs. Milligan-Morgan hemorrhoidectomy: a long-term randomized trial.
- The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia.
- Urinary cyclic adenosine monophosphate discriminates subsets of patients with osteoporosis.
- Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach.
- Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
- Preoperative imaging of parathyroid carcinoma by positron emission tomography.
- Diphosphonates in the treatment of osteoporosis.
- Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET.
- Regional body FDG-PET in postoperative recurrent hyperparathyroidism.
- Angiotropic large-cell lymphoma in a patient with adrenal insufficiency.
- Endocrine management of the open heart surgical patient.
- Effect of a pulsing electromagnetic field on metabolically derived osteoporosis in rats: a pilot study.
- Some thoughts on osteoporosis in women.
- Treatment of hyperparathyroidism with etidronate disodium.
- Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D.
- Whipple's disease presenting as adrenal insufficiency.
- Risedronate, a novel pyridinyl bisphosphonate for the treatment of osteoporosis and Paget''s disease of bone.
- Amiodarone induced hyperthyroidism: a case series and brief review of literature.
- Relationship of parathyroid adenoma volume and biochemical function.
- "Does she or doesn't she...have osteoporosis?" The use and abuse of bone densitometry.
- Therapies for symptomatic primary osteoporosis.
- Effect of supplemental calcium on serum and urinary calcium in osteoporotic patients.
- Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
- Hyperparathyroidism, hyperthyroidism, and Cushing's disease.
- Metastatic carcinoma of the prostate with hypercalcemia.
- Aggressive prevention is key to osteoporosis control.
- Monitoring calcium intake and absorption.
- Monitoring calcium intake in osteoporosis by assay of nephrogenous cyclic AMP.
- Antacid-induced osteomalacia.
- Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease.
- Stress fractures in young athletic women: case reports of unsuspected cortisol-induced osteoporosis.
- Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children.
- Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
- Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.
- Ultrasound of the skeleton: review of its clinical applications and pitfalls.
- Risk of new vertebral fracture in the year following a fracture.
- Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers.
- Bisphosphonate therapy.
- Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
- Gorham's syndrome: a case report and review of the literature.
- Asymptomatic hypercalcemia in a 51-year-old woman.
- Prevention and osteoporosis management.
- Tolerability of risedronate in postmenopausal women intolerant of alendronate.
- Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
- Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
- From bathtub ring to osteoporosis: a clinical review of the bisphosphonates.
- Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms.
- Raloxifene: a new choice for treating and preventing osteoporosis.
- Chemical and histological features of men with osteoporosis.
- Role of alendronate and risedronate in preventing and treating osteoporosis.
- Transient osteoporosis of the hip: clinical and imaging features.
- Practice variation in the diagnosis and treatment of osteoporosis: a case for more effective physician education in primary care.
- Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
- Bone density vs bone quality: what's a clinician to do?
- Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D.
- Development and validation of a predictive bone fracture risk model for astronauts.
- Etidronate: what is its place in treatment of primary osteoporosis and other demineralizing diseases today?
- Active crohn disease and hypercalcemia treated with infliximab: case report and literature review.
- Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).
- A 51-year-old woman with debilitating cramps 12 years after bariatric surgery.
- Osteoporosis in men: suspect secondary disease first.
- Clinical perspectives on bone quality in osteoporosis: effects of drug therapy.
Schools
University Of Rochester School Of Medicine and Dentistry
Washington University Hosps
Georgetown University Hosps
National Institute Health
Doctors Specialties
- Internal Medicine
- Endocrinology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Northern Ohio Live
- Fellow (FACE)
Education
-
Washington University - Barnes-Jewish Hospital -
University of Rochester School of Medicine and Dentistry
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1225134760 | |
| NPPES Provider LastName | LICATA | |
| NPPES Provider FirstName | ANGELO | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 220.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225134760 |
| Last Name Of The Provider | LICATA |
| First Name Of The Provider | ANGELO |
| View All |
Similar Doctors
|
|
Dr. Luis A. Llerena, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison R. Laboon, MD |
|
|
Dr. Rafael S. Cires, MD |
|
|
Dr. Janice E. Douglas, MD |
|
|
Dr. Rahfa K. Zerikly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Korina Shulemovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kavita Nyalakonda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seda Suvag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leann Olansky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Vidhya Karivedu
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Georgiana A. Dobri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Poonam Sood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laleh Razavi Nematollahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariam D. Stevens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arina M. Gliga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pratima Sood, MD |
|
|
Dr. Hacer Guvenc Bicer, MD |